Â
Latest Whipple’s Disease Companies Updates:
Grifols Their TAURINOX (sodium taurocholate) received orphan drug designation in the US and EU for treating Whipple's disease, potentially streamlining the approval process.
Takeda Pharmaceuticals Their investigational drug, Entyvio (vedolizumab), is undergoing clinical trials for potential use in Whipple's disease, exploring alternative treatment options.
Roche Diagnostics Launched a new PCR test for detecting Tropheryma whipplei bacteria, the causative agent of Whipple's disease, aimed at improving diagnostic accuracy and speed.
BioFire Diagnostics Their FilmArray Gastrointestinal Panel 2.0 now includes a test for T. whipplei, providing a broader diagnostic tool for gastroenterologists.
List of Whipple’s Disease  Key companies in the market:
- AbbVie Inc. (US)
- Allergan (Republic of Ireland)
- Bayer AG (Germany)
- Bristol-Myers Squibb Company (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Henry Schein, Inc (US)
- Pfizer Inc. (US)